Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2019 Filed Sep 5, 2019 18:00 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
SaleBio-Rad A Common Stock | 1,089 | $333.08 | $362,722.81 |
DisclosureSEC source: 0001652252-19-000020 · edgar.xml · nonDerivative · entry 1 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,011 Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 18:07 UTC |
HUTTON RONALD WVice President and Treasurer
|
GrantRestricted Stock Units · Derivative | 774 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000024 · edgar.xml · derivative · entry 3 HUTTON RONALD W · CIK 0001248073 · Vice President and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 774 Underlying: Bio-Rad A Common Stock · 774 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 18:52 UTC |
TUMOLO ANNETTEExecutive Vice President
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,784 | $0.00 Strike: $333.34 | $0.00 |
DisclosureSEC source: 0001652252-19-000035 · edgar.xml · derivative · entry 4 TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,784 Underlying: Bio-Rad A Common Stock · 2,784 shares Expires 2029-09-03 F4 · derivative.exercise_date: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 18:52 UTC |
TUMOLO ANNETTEExecutive Vice President
|
GrantRestricted Stock Units · Derivative | 2,784 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000035 · edgar.xml · derivative · entry 3 TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,784 Underlying: Bio-Rad A Common Stock · 2,784 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 18:22 UTC |
STARK JAMES RVP, Corporate Controller
|
GrantRestricted Stock Units · Derivative | 774 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000030 · edgar.xml · derivative · entry 3 STARK JAMES R · CIK 0001248083 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 774 Underlying: Bio-Rad A Common Stock · 774 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 18:17 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President and CEO · 10% owner
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 11,597 | $0.00 Strike: $333.34 | $0.00 |
DisclosureSEC source: 0001652252-19-000028 · edgar.xml · derivative · entry 7 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,597 Underlying: Bio-Rad A Common Stock · 11,597 shares Expires 2029-09-03 F6 · derivative.exercise_date: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 18:17 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President and CEO · 10% owner
|
GrantRestricted Stock Units · Derivative | 11,597 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000028 · edgar.xml · derivative · entry 6 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,597 Underlying: Bio-Rad A Common Stock · 11,597 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. F5 · derivative.expiration_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 18:11 UTC |
Magni GiovanniEVP, Chief Strategy Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,856 | $0.00 Strike: $333.34 | $0.00 |
DisclosureSEC source: 0001652252-19-000026 · edgar.xml · derivative · entry 4 Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,856 Underlying: Bio-Rad A Common Stock · 1,856 shares Expires 2029-09-03 F4 · derivative.exercise_date: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 18:11 UTC |
Magni GiovanniEVP, Chief Strategy Officer
|
GrantRestricted Stock Units · Derivative | 1,856 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000026 · edgar.xml · derivative · entry 3 Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,856 Underlying: Bio-Rad A Common Stock · 1,856 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 18:04 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,320 | $0.00 Strike: $333.34 | $0.00 |
DisclosureSEC source: 0001652252-19-000022 · edgar.xml · derivative · entry 4 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,320 Underlying: Bio-Rad A Common Stock · 2,320 shares Expires 2029-09-03 F4 · derivative.exercise_date: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 18:04 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
GrantRestricted Stock Units · Derivative | 2,320 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000022 · edgar.xml · derivative · entry 3 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,320 Underlying: Bio-Rad A Common Stock · 2,320 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 18:00 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,784 | $0.00 Strike: $333.34 | $0.00 |
DisclosureSEC source: 0001652252-19-000020 · edgar.xml · derivative · entry 5 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,784 Underlying: Bio-Rad A Common Stock · 2,784 shares Expires 2029-09-03 F4 · derivative.exercise_date: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 18:00 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
GrantRestricted Stock Units · Derivative | 2,784 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000020 · edgar.xml · derivative · entry 4 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,784 Underlying: Bio-Rad A Common Stock · 2,784 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| August 14, 2019 Filed Aug 14, 2019 21:46 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
SaleBio-Rad A Common Stock | 325 | $320.00 | $104,000.00 |
DisclosureSEC source: 0001315406-19-000010 · edgar.xml · nonDerivative · entry 1 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,100 Read SEC document |
| August 14, 2019 Filed Aug 14, 2019 21:51 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
SaleBio-Rad A Common Stock | 310 | $320.00 | $99,200.00 |
DisclosureSEC source: 0001315406-19-000012 · edgar.xml · nonDerivative · entry 1 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102.9692 F1 · balance_after: Includes 23.1042 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/28/2019. Read SEC document |
| May 16, 2019 Filed May 16, 2019 23:01 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
SaleBio-Rad A Common Stock | 309 | $299.31 | $92,485.52 |
DisclosureSEC source: 0001652252-19-000018 · edgar.xml · nonDerivative · entry 3 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389.865 Read SEC document |
| May 16, 2019 Filed May 16, 2019 23:01 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
SaleBio-Rad A Common Stock | 191.7315 | $299.12 | $57,351.30 |
DisclosureSEC source: 0001652252-19-000018 · edgar.xml · nonDerivative · entry 2 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 698.865 Read SEC document |
| May 15, 2019 Filed May 15, 2019 23:03 UTC |
Magni GiovanniEVP, Chief Strategy Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,500 | $0.00 Strike: $74.27 | $0.00 |
DisclosureSEC source: 0001652252-19-000016 · edgar.xml · derivative · entry 3 Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 3,500 shares Expires 2019-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in five equal annual installments beginning on June 10, 2010. Read SEC document |
| May 15, 2019 Filed May 15, 2019 23:03 UTC |
Magni GiovanniEVP, Chief Strategy Officer
|
Tax withholdingBio-Rad A Common Stock | 1,803 | $290.63 | $524,002.10 |
DisclosureSEC source: 0001652252-19-000016 · edgar.xml · nonDerivative · entry 2 Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,617 Read SEC document |
| May 15, 2019 Filed May 15, 2019 23:03 UTC |
Magni GiovanniEVP, Chief Strategy Officer
|
Exercise / conversionBio-Rad A Common Stock | 3,500 | $74.27 | $259,945.00 |
DisclosureSEC source: 0001652252-19-000016 · edgar.xml · nonDerivative · entry 1 Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,420 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2019 Filed May 16, 2019 23:01 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
SaleBio-Rad A Common Stock | 345 | $290.00 | $100,050.00 |
DisclosureSEC source: 0001652252-19-000018 · edgar.xml · nonDerivative · entry 1 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 890.5965 F1 · balance_after: Includes 36.3291 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/29/19. Read SEC document |
| May 13, 2019 Filed May 14, 2019 00:12 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President and CEO · 10% owner
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 37,000 | $0.00 Strike: $75.38 | $0.00 |
DisclosureSEC source: 0001315406-19-000008 · edgar.xml · derivative · entry 6 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad B Common Stock · 37,000 shares Expires 2019-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in five equal annual installments beginning on June 10, 2010. Read SEC document |
| May 13, 2019 Filed May 14, 2019 00:12 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President and CEO · 10% owner
|
Tax withholdingBio-Rad B Common Stock | 22,833 | $296.28 | $6,764,961.24 |
DisclosureSEC source: 0001315406-19-000008 · edgar.xml · nonDerivative · entry 2 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,809 Read SEC document |
| May 13, 2019 Filed May 14, 2019 00:12 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President and CEO · 10% owner
|
Exercise / conversionBio-Rad B Common Stock | 37,000 | $75.38 | $2,789,060.00 |
DisclosureSEC source: 0001315406-19-000008 · edgar.xml · nonDerivative · entry 1 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2019 Filed Apr 30, 2019 18:30 UTC |
Last Andrew J.EVP, Chief Operating Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $299.24 | $0.00 |
DisclosureSEC source: 0001652252-19-000014 · edgar.xml · derivative · entry 2 Last Andrew J. · CIK 0001485088 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Bio-Rad A Common Stock · 5,000 shares Expires 2029-04-29 F3 · derivative.exercise_date: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| April 29, 2019 Filed Apr 30, 2019 18:30 UTC |
Last Andrew J.EVP, Chief Operating Officer
|
GrantRestricted Stock Units · Derivative | 5,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000014 · edgar.xml · derivative · entry 1 Last Andrew J. · CIK 0001485088 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Bio-Rad A Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| April 08, 2019 Filed Apr 9, 2019 21:08 UTC |
Daskal IlanEVP, CFO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,500 | $0.00 Strike: $309.84 | $0.00 |
DisclosureSEC source: 0001652252-19-000008 · edgar.xml · derivative · entry 2 Daskal Ilan · CIK 0001446964 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Bio-Rad A Common Stock · 3,500 shares Expires 2029-04-08 F3 · derivative.exercise_date: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| April 08, 2019 Filed Apr 9, 2019 21:08 UTC |
Daskal IlanEVP, CFO
|
GrantRestricted Stock Units · Derivative | 3,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000008 · edgar.xml · derivative · entry 1 Daskal Ilan · CIK 0001446964 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Bio-Rad A Common Stock · 3,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| December 14, 2018 Filed Dec 15, 2018 00:00 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
SaleBio-Rad A Common Stock | 392 | $248.03 | $97,227.64 |
DisclosureSEC source: 0001315406-18-000011 · edgar.xml · nonDerivative · entry 1 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,425 Read SEC document |
| December 14, 2018 Filed Dec 17, 2018 16:20 UTC |
TSINGOS CHRISTINE AEVP and CFO
|
SaleBio-Rad A Common Stock | 1,411 | $248.00 | $349,928.00 |
DisclosureSEC source: 0001315406-18-000013 · edgar.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,683.0979 Read SEC document |
| December 12, 2018 Filed Dec 12, 2018 22:16 UTC |
STARK JAMES RVP, Corporate Controller
|
SaleBio-Rad A Common Stock | 848 | $254.77 | $216,044.96 |
DisclosureSEC source: 0001652252-18-000093 · edgar.xml · nonDerivative · entry 1 STARK JAMES R · CIK 0001248083 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 11, 2018 Filed Dec 12, 2018 22:07 UTC |
TUMOLO ANNETTEExecutive Vice President
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,200 | $0.00 Strike: $159.32 | $0.00 |
DisclosureSEC source: 0001652252-18-000091 · edgar.xml · derivative · entry 4 TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 Underlying: Bio-Rad A Common Stock · 1,200 shares Expires 2026-09-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vests in five equal annual installments beginning September 7, 2017 Read SEC document |
| December 11, 2018 Filed Dec 12, 2018 22:07 UTC |
TUMOLO ANNETTEExecutive Vice President
|
SaleBio-Rad A Common Stock | 1,200 | $255.00 | $306,000.00 |
DisclosureSEC source: 0001652252-18-000091 · edgar.xml · nonDerivative · entry 3 TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,504.3476 Read SEC document |
| December 11, 2018 Filed Dec 12, 2018 22:07 UTC |
TUMOLO ANNETTEExecutive Vice President
|
Exercise / conversionBio-Rad A Common Stock | 1,200 | $159.32 | $191,184.00 |
DisclosureSEC source: 0001652252-18-000091 · edgar.xml · nonDerivative · entry 2 TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,704.3476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2018 Filed Dec 12, 2018 22:07 UTC |
TUMOLO ANNETTEExecutive Vice President
|
SaleBio-Rad A Common Stock | 1,176 | $254.00 | $298,704.00 |
DisclosureSEC source: 0001652252-18-000091 · edgar.xml · nonDerivative · entry 1 TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,504.3476 Read SEC document |
| December 10, 2018 Filed Jan 3, 2019 23:33 UTC |
SCHWARTZ STEVEN D10% owner
|
GiftBio-Rad B Common Stock | 54 | $0.00 | $0.00 |
DisclosureSEC source: 0001315406-19-000006 · edgar.xml · nonDerivative · entry 4 SCHWARTZ STEVEN D · CIK 0000940804 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 12,771 F1 · ownership.nature: The reporting person disclaims beneficial ownership of these shares. Read SEC document |
| December 10, 2018 Filed Jan 3, 2019 23:33 UTC |
SCHWARTZ STEVEN D10% owner
|
GiftBio-Rad B Common Stock | 54 | $0.00 | $0.00 |
DisclosureSEC source: 0001315406-19-000006 · edgar.xml · nonDerivative · entry 3 SCHWARTZ STEVEN D · CIK 0000940804 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,999 Read SEC document |
| December 10, 2018 Filed Jan 3, 2019 23:25 UTC |
SCHWARTZ ALICE NDirector · 10% owner
|
GiftBio-Rad B Common Stock | 324 | $0.00 | $0.00 |
DisclosureSEC source: 0001315406-19-000002 · edgar.xml · nonDerivative · entry 6 SCHWARTZ ALICE N · CIK 0001248076 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Alice N. Schwartz Revocable Trust Disclosed balance after: 438,920 Read SEC document |
| December 10, 2018 Filed Jan 3, 2019 23:25 UTC |
SCHWARTZ ALICE NDirector · 10% owner
|
GiftBio-Rad A Common Stock | 3,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001315406-19-000002 · edgar.xml · nonDerivative · entry 1 SCHWARTZ ALICE N · CIK 0001248076 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Alice N. Schwartz Revocable Trust Disclosed balance after: 1,796,311 Read SEC document |
| December 10, 2018 Filed Jan 3, 2019 23:30 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
GiftBio-Rad B Common Stock | 54 | $0.00 | $0.00 |
DisclosureSEC source: 0001315406-19-000004 · edgar.xml · nonDerivative · entry 3 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 12,771 F1 · ownership.nature: The reporting person disclaims beneficial ownership of these shares. Read SEC document |
| December 10, 2018 Filed Jan 3, 2019 23:30 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
GiftBio-Rad B Common Stock | 54 | $0.00 | $0.00 |
DisclosureSEC source: 0001315406-19-000004 · edgar.xml · nonDerivative · entry 2 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,642 Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 20:38 UTC |
TUMOLO ANNETTEExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-18-000089 · edgar.xml · derivative · entry 4 TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. F4 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 20:38 UTC |
TUMOLO ANNETTEExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-18-000089 · edgar.xml · derivative · entry 3 TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014. Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 20:38 UTC |
TUMOLO ANNETTEExecutive Vice President
|
Tax withholdingBio-Rad A Common Stock | 347 | $308.37 | $107,004.39 |
DisclosureSEC source: 0001652252-18-000089 · edgar.xml · nonDerivative · entry 2 TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,680.3476 Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 20:38 UTC |
TUMOLO ANNETTEExecutive Vice President
|
Exercise / conversionBio-Rad A Common Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-18-000089 · edgar.xml · nonDerivative · entry 1 TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,027.3476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 20:22 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 3,200 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-18-000087 · edgar.xml · derivative · entry 7 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,400 Underlying: Bio-Rad B Common Stock · 3,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock. F6 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. F6 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 20:22 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 2,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-18-000087 · edgar.xml · derivative · entry 6 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad B Common Stock · 2,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock. F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014. F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014. Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 20:22 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Tax withholdingBio-Rad B Common Stock | 2,877 | $308.37 | $887,180.49 |
DisclosureSEC source: 0001652252-18-000087 · edgar.xml · nonDerivative · entry 3 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,588 Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 20:22 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionBio-Rad B Common Stock | 5,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-18-000087 · edgar.xml · nonDerivative · entry 2 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,465 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class B common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 20:13 UTC |
STARK JAMES RVP, Corporate Controller
|
Exercise / conversionRestricted Stock Units · Derivative | 300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-18-000083 · edgar.xml · derivative · entry 4 STARK JAMES R · CIK 0001248083 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Underlying: Bio-Rad A Common Stock · 300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. F4 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.